< Back to all Breaking News
BPTH
3/6/2019 08:03am
Bio-Path Holdings announces clinical update on Phase 2 prexigebersen trial
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.